Watchlist Price Alert

Eton Pharmaceuticals Inc. (ETON)

NASDAQ: ETON · Real-Time Price · USD

14.30

-0.21 (-1.45%)

At close: Jun 13, 2025, 3:59 PM

14.48

1.25%

After-hours: Jun 13, 2025, 05:54 PM EDT

Eton Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	14.94M	21.39M	16.3M	14.41M	21.3M	12.07M	26.73M	13.16M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	12K	12K	12K	21K	40K	61K	52K	32K
Receivables	5.36M	3.41M	1.85M	5.47M	48K	473K	n/a	n/a
Inventory	15.23M	911K	557K	550K	1.24M	380K	n/a	n/a
Other Current Assets	5.49M	1.13M	1.29M	3.18M	2.12M	2.09M	n/a	n/a
Total Current Assets	41.02M	26.84M	20M	23.6M	24.7M	15.01M	27.5M	13.29M
Property-Plant & Equipment	209K	150K	260K	219K	1M	1.28M	773K	119K
Goodwill & Intangibles	34.88M	4.74M	4.75M	3.62M	575K	725K	n/a	n/a
Total Long-Term Assets	35.1M	4.9M	5.03M	3.86M	1.62M	2.06M	825K	151K
Total Assets	76.12M	31.74M	25.03M	27.46M	26.32M	17.07M	28.33M	13.44M
Account Payables	4.17M	1.85M	1.77M	1.77M	2.34M	575K	1.42M	539K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	-133K	n/a	n/a
Short-Term Debt	n/a	5.38M	1.03M	1.42M	280K	n/a	n/a	n/a
Other Current Liabilities	15.74M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	19.95M	16.24M	6.46M	4.56M	3.79M	1.96M	2.02M	793K
Long-Term Debt	29.81M	n/a	5.38M	5.26M	6.76M	4.54M	n/a	n/a
Other Long-Term Liabilities	1.83M	n/a	n/a	n/a	n/a	n/a	n/a	520K
Total Long-Term Liabilities	31.75M	22K	5.49M	5.28M	6.86M	4.56M	1.42M	520K
Total Liabilities	51.7M	16.26M	11.95M	9.84M	10.66M	6.52M	2.02M	1.31M
Total Debt	29.92M	5.4M	6.52M	6.7M	7.14M	4.56M	n/a	n/a
Common Stock	27K	26K	25K	25K	24K	18K	18K	6K
Retained Earnings	-107.89M	-104.07M	-103.13M	-94.11M	-92.16M	-64.19M	-45.87M	-8.64M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	-19M
Shareholders Equity	24.43M	15.48M	13.08M	17.63M	15.66M	10.55M	26.3M	12.13M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a